Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G M Heijerman

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The Netherlands Journal of Medicine|July 8, 2009
A productive coughD Schild, H G M Heijerman, H P Sleeboom
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 30, 2007
Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patientsE B Wilms, D J Touw, H G M Heijerman
Expert Opinion on Drug Delivery|March 6, 2007
Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patientsE M Westerman, H G M Heijerman, H W Frijlink
Therapeutic Drug Monitoring|April 22, 2006
Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosisE B Wilms, D J Touw, H G M Heijerman
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 18, 2018
Specific airway resistance is a better outcome parameter in bronchial provocation testing compared to FEV<sub>1</sub> in patients with bronchial asthmaS A van Nederveen-Bendien, J Vahl, H G M Heijerman
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2009
Demographics of glucose metabolism in cystic fibrosisJ M W van den Berg, J M Kouwenberg, H G M Heijerman
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 30, 2014
Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215NC L Vreede, M C Berkhout, A J Sprij, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot studyE M Westerman, P P H Le Brun, D J Touw, et al.
Contemporary Clinical Trials Communications|December 19, 2022
The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocolL C Terpstra, J Altenburg, I Bronsveld, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 30, 2013
Importance of bacteriology in upper airways of patients with Cystic FibrosisM C Berkhout, E Rijntjes, L H El Bouazzaoui, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Netherlands Journal of Medicine|July 8, 2009
A productive coughD Schild, H G M Heijerman, H P Sleeboom
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 30, 2007
Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patientsE B Wilms, D J Touw, H G M Heijerman
Expert Opinion on Drug Delivery|March 6, 2007
Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patientsE M Westerman, H G M Heijerman, H W Frijlink
Therapeutic Drug Monitoring|April 22, 2006
Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosisE B Wilms, D J Touw, H G M Heijerman
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 18, 2018
Specific airway resistance is a better outcome parameter in bronchial provocation testing compared to FEV<sub>1</sub> in patients with bronchial asthmaS A van Nederveen-Bendien, J Vahl, H G M Heijerman
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 27, 2009
Demographics of glucose metabolism in cystic fibrosisJ M W van den Berg, J M Kouwenberg, H G M Heijerman
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 30, 2014
Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215NC L Vreede, M C Berkhout, A J Sprij, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot studyE M Westerman, P P H Le Brun, D J Touw, et al.
Contemporary Clinical Trials Communications|December 19, 2022
The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocolL C Terpstra, J Altenburg, I Bronsveld, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 30, 2013
Importance of bacteriology in upper airways of patients with Cystic FibrosisM C Berkhout, E Rijntjes, L H El Bouazzaoui, et al.
Pageof 4